Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katarzyna Bukato"'
Autor:
Katarzyna Bukato, Tomasz Kostrzewa, Antonella Marino Gammazza, Magdalena Gorska-Ponikowska, Sambor Sawicki
Publikováno v:
Cell Communication and Signaling, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Endometrial cancer is the most common gynecologic malignancy found in developed countries. Because therapy can be curative at first, early detection and diagnosis are crucial for successful treatment. Early diagnosis allows patien
Externí odkaz:
https://doaj.org/article/a977eb3c5c184072997626fd2b96da9c
Autor:
Bogna Badyra, Anna Pieczykolan, Damian Kloska, Michal Szymanik, Katarzyna Bukato, Olga Zolnierkiewicz, Aleksandra Kopacz, Albert Jaworski, Anna Molga‐Kaczmarska, Sebastian Pawlak, Marta Targosz-Korecka, Neli Kachamakova-Trojanowska, Anna Grochot-Przeczek, Jerzy Pieczykolan, Katarzyna Poleszak, Marlena Galazka, Alicja Jozkowicz, Bartlomiej Zerek, Piotr Rózga, Malgorzata Teska-Kaminska
Publikováno v:
International journal of cancerReferences. 147(4)
Targeting of the TRAIL-DR4/5 pathway was proposed as a promising approach for specific induction of apoptosis in cancer cells. Clinical trials, however, showed inadequate efficiency of TRAIL as a monotherapy. It is a widely held view that the applica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f8cd0358b596bf579bf0e4e724e33c6
https://pubmed.ncbi.nlm.nih.gov/31863596
https://pubmed.ncbi.nlm.nih.gov/31863596
Autor:
Anna Pieczykolan, Katarzyna Bukato, Sebastian Pawlak, Katarzyna Poleszak, Maciej Masłyk, Albert Jaworski, Konrad Kubiński, Marlena Gałązka, Jerzy Pieczykolan, Wojciech Strozek, Piotr Rózga, Rafal Zielinski, Malgorzata Teska-Kaminska, Michal Szymanik, Bartłomiej Żerek, Robert Świder
Publikováno v:
Investigational new drugs. 32(6)
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors became promising molecules for selective targeting of tumor cells without affecting normal tissue. Unfortunately, cancer cells have developed a number of mechanisms tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb64508a340c32d5ed0dfcdadde6cd8e
https://pubmed.ncbi.nlm.nih.gov/25182378
https://pubmed.ncbi.nlm.nih.gov/25182378
Autor:
Marlena Galazka, Katarzyna Bukato, Sebastian Pawlak, Bartlomiej Zerek, Katarzyna Poleszak, Wojciech Strozek, Piotr Rózga, Malgorzata Teska-Kaminska, Anna Pieczykolan, Jerzy Pieczykolan, Albert Jaworski, Michal Szymanik
Publikováno v:
Cancer Research. 74:2773-2773
Background The tumor necrosis factor related apoptosis-inducing ligand (TRAIL/Apo2L) is a member of the TNF superfamily that initiates apoptosis of tumor cells through the activation of their death receptors. The ability of TRAIL to selectively induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::748f531dabc012fecaf9fd275f3917d8
https://doi.org/10.1158/1538-7445.am2014-2773
https://doi.org/10.1158/1538-7445.am2014-2773
Autor:
Marlena Galazka, Piotr Rózga, Malgorzata Teska-Kaminska, Wojciech Strozek, Jerzy Pieczykolan, Katarzyna Bukato, Sebastian Pawlak, Michal Szymanik, Albert Jaworski, Katarzyna Poleszak, Bartlomiej Zerek, Anna Pieczykolan
Publikováno v:
Cancer Research. 74:4471-4471
Although standard chemotherapy is still one of the most effective treatment for many types of cancer - often causes side effects. Chemotherapeutic agents primarily damage cancer cells with a rapidly dividing and growing profile, thereby also destroy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ebe21c249fa57591530f18b2469cdd8
https://doi.org/10.1158/1538-7445.am2014-4471
https://doi.org/10.1158/1538-7445.am2014-4471
Autor:
Katarzyna Poleszak, Jerzy Pieczykolan, Katarzyna Bukato, Anna Pieczykolan, Sebastian Pawlak, Wojciech Strozek, Michal Szymanik, Albert Jaworski, Piotr Rózga, Malgorzata Teska-Kaminska, Marlena Galaska, Bartlomiej Zerek
Publikováno v:
Cancer Research. 74:3796-3796
Background Cancer growth and development is tightly related to both new vessels formation for tissue remodeling and inhibition of anti-apoptotic signals. Vascular endothelial growth factor (VEGF) is important for vascular development in physiological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a551eef3788ed7f82c1ad95fbb10075
https://doi.org/10.1158/1538-7445.am2014-3796
https://doi.org/10.1158/1538-7445.am2014-3796